Kolon Life Science Inc - ESG Rating & Company Profile powered by AI
Browse to the bottom of this page for potential risks for Kolon Life Science Inc based on sector, geography and marketcap. The assessment of Kolon Life Science Inc incorporates data from across the internet as well as from available documents by Kolon Life Science Inc. The page contains a zero-cost Sustainability analysis for Kolon Life Science Inc.
Kolon Life Science Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Kolon Life Science Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Kolon Life Science Inc have an accelerator or VC vehicle to help deliver innovation?
Does Kolon Life Science Inc disclose current and historical energy intensity?
Does Kolon Life Science Inc report the average age of the workforce?
Does Kolon Life Science Inc reference operational or capital allocation in relation to climate change?
Does Kolon Life Science Inc disclose its ethnicity pay gap?
Does Kolon Life Science Inc disclose cybersecurity risks?
Does Kolon Life Science Inc offer flexible work?
Does Kolon Life Science Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Kolon Life Science Inc disclose the number of employees in R&D functions?
Does Kolon Life Science Inc conduct supply chain audits?
Does Kolon Life Science Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Kolon Life Science Inc conduct 360 degree staff reviews?
Does Kolon Life Science Inc disclose the individual responsible for D&I?
Does Kolon Life Science Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Kolon Life Science Inc disclose current and / or historical scope 2 emissions?
Does Kolon Life Science Inc disclose water use targets?
Does Kolon Life Science Inc have careers partnerships with academic institutions?
Did Kolon Life Science Inc have a product recall in the last two years?
Does Kolon Life Science Inc disclose incidents of discrimination?
Does Kolon Life Science Inc allow for Work Councils/Collective Agreements to be formed?
Has Kolon Life Science Inc issued a profit warning in the past 24 months?
Does Kolon Life Science Inc disclose parental leave metrics?
Does Kolon Life Science Inc disclose climate scenario or pathway analysis?
Does Kolon Life Science Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Kolon Life Science Inc disclose the pay ratio of women to men?
Does Kolon Life Science Inc support suppliers with sustainability related research and development?
Does Kolon Life Science Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Kolon Life Science Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Kolon Life Science Inc involved in embryonic stem cell research?
Does Kolon Life Science Inc disclose GHG and Air Emissions intensity?
Does Kolon Life Science Inc disclose its waste policy?
Does Kolon Life Science Inc report according to TCFD requirements?
Does Kolon Life Science Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Kolon Life Science Inc disclose energy use targets?
Does Kolon Life Science Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Kolon Life Science Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Kolon Life Science Inc
These potential risks are based on the size, segment and geographies of the company.
Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, pyrithione antimicrobials, and water solutions primarily in South Korea. Its biopharmaceutical product under development comprise KLS-1020, a cancer vaccine; KLS-3021, a oncolytic viral therapy; and KLS-2031 for treatment for neuropathic pain. The company also provides active pharmaceutical ingredients for anti-cancer and intermediates; and pyrithione antimicrobial for shampoo and soap bars, cosmetic and wet wipes, fabric softeners, metalworking fluids, antifouling paints, and fire-fighters. In addition, it offers Kolon BESFLOC polymer used in chemical, food, leather, pharmaceutical, textile, and dairy industries, as well as in settling reservoirs, sludge thickeners, floating reservoirs, and dehydrators in sewage treatment plants. The company was formerly known as Korea Tissuegene Asia, Ltd. and changed its name to Kolon Life Science Inc. in January 2006. Kolon Life Science Inc. was founded in 2000 and is headquartered in Seoul, South Korea.